Herbas VPB

Print
EN | LT
LT - COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES
EN - COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/437
A61K 38/13
A61P 1/00
A61P 1/12
European patent
(11) Number of the document 3160467
(13) Kind of document T
(96) European patent application number 15815195.1
Date of filing the European patent application 2015-05-04
(97) Date of publication of the European application 2017-05-03
(45) Date of publication and mention of the grant of the patent 2021-03-10
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/029083
Date 2015-05-04
PCT application publication
(87) Number WO 2016/003536
Date 2016-01-07
Priority applications
(30) Number Date Country code
201462019388 P 2014-06-30 US
201462036097 P 2014-08-11 US
Inventors
(72)
GOLDEN, Pam, US
BORTEY, Enoch, US
FORBES, William, US
PATERSON, Craig, US
Grantee
(73) Salix Pharmaceuticals, Inc., 400 Somerset Corporate Boulevard, Bridgewater, NJ 08807, US
Title
(54) COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES
  COMBINATION COMPRISING RIFAXIMIN AND CYCLOSPORINE FOR USE IN THE TREATMENT OF BOWEL DISEASES
Last update date 2021-06-30